A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT07821944
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT07821944
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- India
- Registry status
- Recruiting
Technical summary
Registry record NCT07821944. Randomized; triple masking; primary purpose treatment. Start 2026-10-15 (actual); primary completion 2027-11-26 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
- Condition
- Hyperlipidemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Enlicitide Decanoate
- Intervention (Other)
- Placebo
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct07821944- Content hash
1028bb05b76f2ebf9833e47e04ffeb5f795d6e8e508720a1382adf20f1d7e22b